banner
Home / News / The Infusion Pump Market to grow by USD 5,085.17 million from 2022 to 2027
News

The Infusion Pump Market to grow by USD 5,085.17 million from 2022 to 2027

Jun 17, 2023Jun 17, 2023

News provided by

02 Aug, 2023, 11:20 ET

Share this article

NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The infusion pump market is estimated to grow by USD 5,085.17 million at a CAGR of 7.27% from 2022 to 2027. Discover some insights on market size historic period (2017 to 2021) and Forecast (2023 to 2027) before buying the full report -Request a sample report

Infusion pump market – Vendor AnalysisVendor Landscape - The infusion pump market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer infusion pumps in the market are ADOX SA, Arcomed AG, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Beijing KellyMed Co. Ltd., CODAN ARGUS AG, Digicare Biomedical Technology Inc., Eitan Medical Ltd., Flowonix Medical Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic Plc, Mindray Biomedical Electronics Co. Ltd., Nipro Corp., Silverline Meditech Pvt. Ltd., Terumo Corp., vTitan Corp. Pvt Ltd., and Zyno Medical and others.

What's New? -

Vendor Offerings -

Infusion Pump Market - Segmentation Assessment

Segment OverviewTechnavio has segmented the market based on Type (Insulin pumps, Volumetric pumps, Elastomeric pumps, Enteral pumps, and Others), End-user (Hospitals, Ambulatory service centers, and Clinics), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

Geography OverviewBy geography, the global infusion pump market is segmented into North America, Europe, Asia, and the Rest of the World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global infusion pump market.

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a Sample Report

Infusion Pump Market – Market Dynamics

Key drivers

The growing demand for long-term management and medical treatment of diseases is a key factor driving market growth. The regular implementation of accurate and controlled measurements and the growing need for intravenous treatment have increased the demand for insulin pumps. The importance of insulin pumps in the management of age-related diseases and increasing awareness of medication therapies and fluid management for the aging population of the world are further driving the growth of the market. Hence, these factors are expected to drive market growth during the forecast period.

Major Trends

The high demand for advanced infusion pumps is a major trend in the market. The latest generation infusion pumps incorporate advanced features and technologies such as barcode scanning systems and sensors to improve patient safety, medication accuracy, and user comfort. Additionally, some pumps can be integrated with electronic medical records (EMR) or barcode scanning systems to further secure drug delivery and minimize the risk of error. Hence, the rising adoption of advanced infusion pumps is expected to drive market growth during the forecast period.

Significant Challenges

The stringent regulatory requirement on medical devices is a significant challenge restricting the market growth. In the United States, the Food and Drug Administration (FDA) oversees the regulation of infusion pumps under the Federal Food, Drug, and Cosmetic Act (FD Act and C Act) and Title 21 of the Code of Federal Regulations (CFR). Manufacturers must comply with these regulations to meet safety and performance standards. Compliance with these standards ensures the safety and efficacy of infusion pumps used in healthcare settings. Failure to comply with regulatory requirements can have a variety of consequences, including penalties, Product Recalls, and Loss of Market Approval. Hence, these factors are expected to restrict market growth during the forecast period.

Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this Infusion Pump Market report?

Gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Related Reports

The elastomeric infusion pumps market is estimated to grow by USD 800.97 million at a CAGR of 7.07% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (pain management, antibiotic or antiviral, chemotherapy, and others), end-user (hospitals, ambulatory service centers, clinics, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The high demand for advanced infusion pumps is a major trend in the market.

The MRI-compatible IV infusion pumps market is projected to grow by USD 126.79 million with a CAGR of 7.41% during the forecast period 2021 to 2026. Furthermore, this report extensively covers the MRI-compatible IV infusion pumps market segmentation by product type (pumps and tubing and disposables) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The high growth potential in emerging economies is a major trend in the market.

Infusion Pump Market Scope

Report Coverage

Details

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.27%

Market growth 2023-2027

USD 5,085.17 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.28

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 43%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

ADOX SA, Arcomed AG, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Beijing KellyMed Co. Ltd., CODAN ARGUS AG, Digicare Biomedical Technology Inc., Eitan Medical Ltd., Flowonix Medical Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic Plc, Mindray Biomedical Electronics Co. Ltd., Nipro Corp., Silverline Meditech Pvt. Ltd., Terumo Corp., vTitan Corp. Pvt Ltd., and Zyno Medical

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Market Segmentation by End-user

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected]Website: www.technavio.com

SOURCE Technavio

Technavio